RECRUITING

A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)

Description

The goal of this study is to learn what happens to enlicitide in a person's body over time when enlicitide is taken at the same time as coffee or tea. Researchers will measure the amount of enlicitide in the blood when taken with coffee or tea compared with enlicitide taken with water.

Conditions

Healthy
Talk to us

Related Conditions:

Healthy

Study Overview

On this page

Study Details

Study overview

The goal of this study is to learn what happens to enlicitide in a person's body over time when enlicitide is taken at the same time as coffee or tea. Researchers will measure the amount of enlicitide in the blood when taken with coffee or tea compared with enlicitide taken with water.

A Clinical Study to Evaluate the Effects of Coffee and Tea on the Pharmacokinetics of Enlicitide in Healthy Adult Participants

A Clinical Study of How Coffee and Tea Affect Enlicitide in Healthy Volunteers (MK-0616-040)

Condition
Healthy
Intervention / Treatment

-

Contacts and Locations

Tempe

Celerion, Inc. ( Site 0001), Tempe, Arizona, United States, 85283

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Is in good health
  • * Is a non-smoker for at least 3 months prior to study entry
  • * Part 1 only: Consumes at least 1 cup of caffeinated coffee per day
  • * Part 2 only: Consumes at least 1 cup of caffeinated tea per day
  • * Has a history or presence of clinically significant medical or psychiatric condition or disease
  • * History of gastrointestinal disease which might affect food and drug absorption, or has had gastric bypass or similar surgery.

Ages Eligible for Study

18 Years to 55 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Merck Sharp & Dohme LLC,

Medical Director, STUDY_DIRECTOR, Merck Sharp & Dohme LLC

Study Record Dates

2025-08-20